Biophytis Announces Combined General Meeting on June 24, 2024

Paris, France, and Cambridge, USA – June 7, 2024 – Biophytis SA, a clinical-stage biotechnology company, will hold its Combined General Meeting (CGM) on June 24, 2024, at Sorbonne Université in Paris.

The notice of meeting, which includes the agenda and draft resolutions, was published in Bulletin des Annonces Légales Obligatoires on May 15, 2024. Detailed information and preparatory documents, including the voting form and access map, are available on the company's website.

Shareholders are encouraged to vote in advance by post, by appointing the Chairman as proxy, or via the VOTACCESS online platform. Votes must be submitted by June 21, 2024, for postal and proxy votes, and by June 23, 2024, via VOTACCESS.